0001011443-20-000005.txt : 20200214 0001011443-20-000005.hdr.sgml : 20200214 20200214145430 ACCESSION NUMBER: 0001011443-20-000005 CONFORMED SUBMISSION TYPE: 13F-HR/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20200214 DATE AS OF CHANGE: 20200214 EFFECTIVENESS DATE: 20200214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HBK INVESTMENTS L P CENTRAL INDEX KEY: 0001011443 IRS NUMBER: 752622581 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR/A SEC ACT: 1934 Act SEC FILE NUMBER: 028-06078 FILM NUMBER: 20618366 BUSINESS ADDRESS: STREET 1: 2300 NORTH FIELD STREET STREET 2: STE 2200 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: 2147586100 MAIL ADDRESS: STREET 1: 2300 NORTH FIELD STREET STREET 2: STE 2200 CITY: DALLAS STATE: TX ZIP: 75201 13F-HR/A 1 primary_doc.xml 13F-HR/A LIVE false false false 0001011443 XXXXXXXX 06-30-2018 06-30-2018 true 2 NEW HOLDINGS true 02-14-2020 02-14-2020 Confidential Treatment Expired HBK INVESTMENTS L P

2300 NORTH FIELD STREET STE 2200 DALLAS TX 75201

13F HOLDINGS REPORT 028-06078 Y HBK Investments L.P. has delegated discretion to vote and dispose of the securities described below to HBK Services LLC ("Services"). Services may, from time to time, delegate discretion to vote and dispose of certain of such Securities to one or more subadvisors. Each of Services and such subadvisors is under common control with HBK Investments L.P. The filing of this report shall not be deemed an admission that such subadvisors are, for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, beneficial owners of such securities. Isaac Haas 214-758-6107 Isaac Haas Dallas TX 02-14-2020 0 2 1457983 INFORMATION TABLE 2 a2q2confi2public2019.xml Q2 A2 2019 CONFI TO PUBLIC CELGENE CORP COM 151020104 1437497 15550600 SH SOLE 15550600 0 0 SPARK THERAPEUTICS INC COM 84652J103 20486 200100 SH SOLE 200100 0 0